Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 92 (RPL23AP92)

Target
RPL23AP92
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L23a pseudogene 92 (RPL23AP92) is a human pseudogene that shares sequence similarity with the gene encoding ribosomal protein L23a but does not produce a functional protein product[2][5]. Pseudogenes are DNA segments resembling normal genes but generally nonfunctional due to mutations or lack of regulatory elements. There is currently no evidence suggesting that RPL23AP92 encodes a functional protein or plays an active role in cellular processes or disease; accordingly, it is not considered a therapeutic target or biomarker, and there are no associated interacting drugs or drug mechanisms[2][5]. This pseudogene is distinct from ribosomal protein L23a itself and should not be confused with other L23a pseudogenes (of which more than 100 exist in the human genome)[3]. At this time, nothing suggests a role for RPL23AP92 in disease biology or its utility as a molecular or therapeutic target.

Other names
RPL23AP92
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 92 (RPL23AP92).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 92 (RPL23AP92).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call